Calendar

Apr 26, 2026constraining patent expiry europe107d agoBlue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Europe))BB-101

Therapy area: Dermatology. Indication: Diabetic Foot Ulcers

full page →BB-101 →source: globaldata

Apr 26, 2026patent expiry107d agoBlue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Japan))BB-101

Therapy area: Dermatology. Indication: Diabetic Foot Ulcers

full page →BB-101 →source: globaldata

Apr 26, 2026phase 2 completion107d agoChongqing Jinsaixing Medical Technology Co Ltd — Neauvia Intense (Phase II Trial Completion)Neauvia Intense

Therapy area: Dermatology. Indication: Wrinkles

full page →Neauvia Intense →source: globaldata

Apr 26, 2026phase 2 initiation107d agoChittagong Medical College — difelikefalin (Phase II Trial Initiation)difelikefalin

Therapy area: Dermatology, Genito Urinary System. Indication: Chronic Kidney Disease (Chronic Renal Failure), Pruritus

full page →difelikefalin →source: globaldata

Apr 26, 2026phase iii iv trial completion107d agoRajaRajeswari Medical College & Hospital — stromal vascular fraction (Phase III/IV Trial Completion)stromal vascular fraction

Therapy area: Dermatology. Indication: Androgenic Alopecia

full page →stromal vascular fraction →source: globaldata

Week of Apr 20, 2026